Benefits and harms of antihypertensive treatment in low-risk patients mild hypertension
<p>Importance: Evidence to support initiation of pharmacologic treatment in low-risk patients with mild hypertension is inconclusive, with previous trials underpowered to demonstrate benefit. Clinical guidelines across the world are contradictory.</p><p> Objective: To examine wheth...
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Journal article |
| Vydáno: |
American Medical Association
2018
|